Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism

Toxicology in Vitro

Volumn 20, Issue 2, 2006, Pages 187-210

  Moon, Young Jin ^a   Wang, Xiaodong ^a   Morris, Marilyn E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Carcinogen; CYP; Dietary flavonoids; Phase II enzymes; Xenobiotic metabolism

Indexed keywords

ACACETIN; ANTHOCYANIN; AURANTIIN; BAICALEIN; BIOCHANIN A; CHALCONE; CHRYSIN; DAIDZEIN; DIOSMETIN; DIOSMIN; EQUOL; FISETIN; FLAVANOL DERIVATIVE; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; GALANGIN; GENISTEIN; GENISTIN; GREEN TEA EXTRACT; HESPERETIN; ISOFLAVONE; KAEMPFEROL; NARINGENIN; QUERCETIN; TANGERETIN; THEAFLAVIN; XANTHOHUMOL;

BEVERAGE; BREAST CANCER; CANCER PREVENTION; CARCINOGENICITY; DETOXIFICATION; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG SULFATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; FRUIT; GINKGO BILOBA; HEALTH PROMOTION; HERBAL MEDICINE; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROSTATE CANCER; SHORT SURVEY; SILYBUM MARIANUM; TISSUE DISTRIBUTION; VEGETABLE; XENOBIOTIC METABOLISM;

GINKGO BILOBA; SILYBUM; SILYBUM MARIANUM;

EID: 30644456411     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2005.06.048     Document Type: Review

References (209)

1. H. Adlercreutz, C. Bannwart, K. Wahala, T. Makela, G. Brunow, T. Hase, P.J. Arosemena, J.T. Kellis Jr., and L.E. Vickery Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens J. Steroid Biochem. Mol. Biol. 44 1993 147 153
2. K. Almstrup, M.F. Fernandez, J.H. Petersen, N. Olea, N.E. Skakkebaek, and H. Leffers Dual effects of phytoestrogens result in u-shaped dose-response curves Environ. Health Perspect. 110 2002 743 748
3. B. Ameer, and R.A. Weintraub Drug interactions with grapefruit juice Clin. Pharmacokinet. 33 1997 103 121
4. P.J. Ansell, C. Espinosa-Nicholas, E.M. Curran, B.M. Judy, B.J. Philips, M. Hannink, and D.B. Lubahn In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens Endocrinology 145 2004 311 317
5. Z. Apostolides, D.A. Balentine, M.E. Harbowy, Y. Hara, and J.H. Weisburger Inhibition of PhIP mutagenicity by catechins, and by theaflavins and gallate esters Mutat. Res. 389 1997 167 172
6. L.C. Appelt, and M.M. Reicks Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats J. Nutr. 129 1999 1820 1826
7. J.T. Backman, J. Maenpaa, D.J. Belle, S.A. Wrighton, K.T. Kivisto, and P.J. Neuvonen Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation Clin. Pharmacol. Ther. 67 2000 382 390
8. D.G. Bailey, J.M. Arnold, and J.D. Spence Grapefruit juice and drugs. How significant is the interaction? Clin. Pharmacokinet. 26 1994 91 98
9. D.G. Bailey, G.K. Dresser, J.H. Kreeft, C. Munoz, D.J. Freeman, and J.R. Bend Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients Clin. Pharmacol. Ther. 68 2000 468 477
10. J. Barnes, L.A. Anderson, and J.D. Phillipson St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties J. Pharm. Pharmacol. 53 2001 583 600
11. D.G. Batt, R. Goodman, D.G. Jones, J.S. Kerr, L.R. Mantegna, C. McAllister, R.C. Newton, S. Nurnberg, P.K. Welch, and M.B. Covington 2'-Substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis J. Med. Chem. 36 1993 1434 1442
12. S. Beckmann-Knopp, S. Rietbrock, R. Weyhenmeyer, R.H. Bocker, K.T. Beckurts, W. Lang, M. Hunz, and U. Fuhr Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes Pharmacol. Toxicol. 86 2000 250 256
13. G.R. Beecher Overview of dietary flavonoids: nomenclature, occurrence and intake J. Nutr. 133 2003 3248S 3254S
14. J. Bomser, D.L. Madhavi, K. Singletary, and M.A. Smith In vitro anticancer activity of fruit extracts from vaccinium species Planta Med. 62 1996 212 216
15. B.J. Bray, N.B. Perry, D.B. Menkes, and R.J. Rosengren Toxicol. Sci. 66 2002 27 33
16. V.M. Breinholt, E.A. Offord, C. Brouwer, S.E. Nielsen, K. Brosen, and T. Friedberg In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids Food Chem. Toxicol. 40 2002 609 616
17. K. Brosen Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2 Clin. Pharmacokinet. 29 Suppl 1 1995 20 25
18. C. Brouard, M.H. Siess, M.F. Vernevaut, and M. Suschetet Comparison of the effects of feeding quercetin or flavone on hepatic and intestinal drug-metabolizing enzymes of the rat Food Chem. Toxicol. 26 1988 99 103
19. R.W. Brueggemeier, J.A. Richards, S. Joomprabutra, A.S. Bhat, and J.L. Whetstone Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents J. Steroid Biochem. Mol. Biol. 79 2001 75 84
20. A. Bu-Abbas, M.N. Clifford, C. Ioannides, and R. Walker Stimulation of rat hepatic UDP-glucuronosyl transferase activity following treatment with green tea Food Chem. Toxicol. 33 1995 27 30
21. D.R. Campbell, and M.S. Kurzer Flavonoid inhibition of aromatase enzyme activity in human preadipocytes J. Steroid Biochem. Mol. Biol. 46 1993 381 388
22. M.C. Canivenc-Lavier, M.F. Vernevaut, M. Totis, M.H. Siess, J. Magdalou, and M. Suschetet Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver Toxicology 114 1996 19 27
23. W.J. Catalona, D.S. Smith, T.L. Ratliff, K.M. Dodds, D.E. Coplen, J.J. Yuan, J.A. Petros, and G.L. Andriole Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N. Engl. J. Med. 324 1991 1156 1161
24. F. Catterall, N.J. McArdle, L. Mitchell, A. Papayanni, M.N. Clifford, and C. Ioannides Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins Food Chem. Toxicol. 41 2003 1141 1147
25. H.Y. Chan, Z.Y. Chen, D.S. Tsang, and L.K. Leung Baicalein inhibits DMBA-DNA adduct formation by modulating CYP1A1 and CYP1B1 activities Biomed. Pharmacother. 56 2002 269 275
26. H.Y. Chan, and L.K. Leung A potential protective mechanism of soya isoflavones against 7,12-dimethylbenz[a]anthracene tumour initiation Br. J. Nutr. 90 2003 457 465
27. H.Y. Chan, H. Wang, and L.K. Leung The red clover (Trifolium pratense) isoflavone biochanin A modulates the biotransformation pathways of 7,12-dimethylbenz[a]anthracene Br. J. Nutr. 90 2003 87 92
28. L.C. Chang, C. Gerhauser, L. Song, N.R. Farnsworth, J.M. Pezzuto, and A.D. Kinghorn Activity-guided isolation of constituents of Tephrosia purpurea with the potential to induce the phase II enzyme, quinone reductase J. Nat. Prod. 60 1997 869 873
29. C. Chen, and A.N. Kong Dietary chemopreventive compounds and ARE/EpRE signaling Free Radic. Biol. Med. 36 2004 1505 1516
30. J. Chen, S.C. Halls, J.F. Alfaro, Z. Zhou, and M. Hu Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes Pharm. Res. 21 2004 2095 2104
31. S. Chlopcikova, J. Psotova, P. Miketova, and V. Simanek Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans Phytother. Res. 18 2004 107 110
32. H.P. Ciolino, P.J. Daschner, and G.C. Yeh Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially Biochem. J. 340 Pt 3 1999 715 722
33. H.P. Ciolino, T.T. Wang, and G.C. Yeh Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity Cancer Res. 58 1998 2754 2760
34. H.P. Ciolino, and G.C. Yeh The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor Br. J. Cancer 79 1999 1340 1346
35. A.H. Conney Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S Goodman Lecture. Cancer Res. 63 2003 7005 7031
36. M.W. Coughtrie, and L.E. Johnston Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance Drug Metab. Dispos. 29 2001 522 528
37. M.W. Coughtrie, S. Sharp, K. Maxwell, and N.P. Innes Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases Chem. Biol. Interact. 109 1998 3 27
38. M. Cushman, D. Nagarathnam, D.L. Burg, and R.L. Geahlen Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues J. Med. Chem. 34 1991 798 806
39. R. Dai, S. Zhai, X. Wei, M.R. Pincus, R.E. Vestal, and F.K. Friedman Inhibition of human cytochrome P450 1A2 by flavones: a molecular modeling study J. Protein Chem. 17 1998 643 650
40. C. De Santi, A. Pietrabissa, R. Spisni, F. Mosca, and G.M. Pacifici Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum Xenobiotica 30 2000 609 617
41. R. De Vincenzo, C. Ferlini, M. Distefano, C. Gaggini, A. Riva, E. Bombardelli, P. Morazzoni, P. Valenti, F. Belluti, F.O. Ranelletti, S. Mancuso, and G. Scambia In vitro evaluation of newly developed chalcone analogues in human cancer cells Cancer Chemother. Pharmacol. 46 2000 305 312
42. F. Depeint, J.M. Gee, G. Williamson, and I.T. Johnson Evidence for consistent patterns between flavonoid structures and cellular activities Proc. Nutr. Soc. 61 2002 97 103
43. R. DiCenzo, M. Shelton, K. Jordan, C. Koval, A. Forrest, R. Reichman, and G. Morse Coadministration of milk thistle and indinavir in healthy subjects Pharmacotherapy 23 2003 866 870
44. A.T. Dinkova-Kostova Protection against cancer by plant phenylpropenoids: induction of mammalian anticarcinogenic enzymes Mini. Rev. Med. Chem. 2 2002 595 610
45. A.T. Dinkova-Kostova, M.A. Massiah, R.E. Bozak, R.J. Hicks, and P. Talalay Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups Proc. Natl. Acad. Sci. USA 98 2001 3404 3409
46. D.R. Doerge, and H.C. Chang Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 777 2002 269 279
47. J.L. Donovan, K.D. Chavin, C.L. Devane, R.M. Taylor, J.S. Wang, Y. Ruan, and J.S. Markowitz Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers Drug Metab. Dispos. 32 2004 906 908
48. H. Doostdar, M.D. Burke, and R.T. Mayer Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1 Toxicology 144 2000 31 38
49. D. Durr, B. Stieger, G.A. Kullak-Ublick, K.M. Rentsch, H.C. Steinert, P.J. Meier, and K. Fattinger St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 Clin. Pharmacol. Ther. 68 2000 598 604
50. E.A. Eaton, U.K. Walle, A.J. Lewis, T. Hudson, A.A. Wilson, and T. Walle Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention Drug Metab. Dispos. 24 1996 232 237
51. A.M Evans Influence of dietary components on the gastrointestinal metabolism and transport of drugs Ther. Drug Monit. 22 2000 131 136
52. J.W. Fahey, and K.K. Stephenson Pinostrobin from honey and Thai ginger (Boesenbergia pandurata): a potent flavonoid inducer of mammalian phase 2 chemoprotective and antioxidant enzymes J. Agric. Food Chem. 50 2002 7472 7476
53. Q. Feng, Y. Torii, K. Uchida, Y. Nakamura, Y. Hara, and T. Osawa Black tea polyphenols, theaflavins, prevent cellular DNA damage by inhibiting oxidative stress and suppressing cytochrome P450 1A1 in cell cultures J. Agric. Food Chem. 50 2002 213 220
54. M.J. Finnen, and K.A. Hassall Effects of hypophysectomy on sex differences in the induction and depression of hepatic drug-metabolizing enzymes in the rat J. Pharmacol. Exp. Ther. 229 1984 250 254
55. B.C. Foster, S. Vandenhoek, J. Hana, A. Krantis, M.H. Akhtar, M. Bryan, J.W. Budzinski, A. Ramputh, and J.T. Arnason In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products Phytomedicine 10 2003 334 342
56. U. Fuhr Drug interactions with grapefruit juice. Extent probable mechanism and clinical relevance Drug Saf. 18 1998 251 272
57. U. Fuhr, K. Klittich, and A.H. Staib Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man Br. J. Clin. Pharmacol. 35 1993 431 436
58. A. Galijatovic, Y. Otake, U.K. Walle, and T. Walle Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells-potential role in carcinogen bioinactivation Pharm. Res. 18 2001 374 379
59. C. Gambelunghe, R. Rossi, M. Sommavilla, C. Ferranti, C. Ciculi, S. Gizzi, A. Micheletti, and S. Rufini Effects of chrysin on urinary testosterone levels in human males J. Med. Food 6 2003 387 390
60. R.A. Ghazali, and R.H. Waring The effects of flavonoids on human phenolsulphotransferases: potential in drug metabolism and chemoprevention Life Sci. 65 1999 1625 1632
61. B. Gil, M.J. Sanz, M.C. Terencio, M.L. Ferrandiz, G. Bustos, M. Paya, R. Gunasegaran, and M.J. Alcaraz Effects of flavonoids on Naja naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice Life Sci. 54 1994 PL333 PL338
62. H. Glatt Sulfotransferases in the bioactivation of xenobiotics Chem. Biol. Interact. 129 2000 141 170
63. B. Goodwin, L.B. Moore, C.M. Stoltz, D.D. McKee, and S.A. Kliewer Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor Mol. Pharmacol. 60 2001 427 431
64. H.N. Graham Green tea composition, consumption, and polyphenol chemistry Prev. Med. 21 1992 334 350
65. F.P. Guengerich, D.H. Kim, and M. Iwasaki Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects Chem. Res. Toxicol. 4 1991 168 179
66. F.P. Guengerich, and T. Shimada Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes Chem. Res. Toxicol. 4 1991 391 407
67. B.J. Gurley, S.F. Gardner, M.A. Hubbard, D.K. Williams, W.B. Gentry, J. Carrier, I.A. Khan, D.J. Edwards, and A. Shah In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto Clin. Pharmacol. Ther. 76 2004 428 440
68. R.M. Harris, D.M. Wood, L. Bottomley, S. Blagg, K. Owen, P.J. Hughes, R.H. Waring, and C.J. Kirk Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment J. Clin. Endocrinol. Metab. 89 2004 1779 1787
69. J.D. Hayes, and M. McMahon Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention Cancer Lett. 174 2001 103 113
70. J.D. Hayes, and D.J. Pulford The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit. Rev. Biochem. Mol. Biol. 30 1995 445 600
71. L.M. Heffernan, and G.W. Winston Distribution of microsomal CO-binding chromophores and EROD activity in sea anemone tissues Mar. Environ. Res. 50 2000 23 27
72. N.A. Helsby, J.K. Chipman, A. Gescher, and D. Kerr Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol Food Chem. Toxicol. 36 1998 375 382
73. N.A. Helsby, J. Williams, D. Kerr, A. Gescher, and J.K. Chipman The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells Xenobiotica 27 1997 587 596
74. M.C. Henderson, C.L. Miranda, J.F. Stevens, M.L. Deinzer, and D.R. Buhler In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus Xenobiotica 30 2000 235 251
75. P.C. Ho, D.J. Saville, and S. Wanwimolruk Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds J. Pharm. Pharm. Sci. 4 2001 217 227
76. P. Hodek, P. Trefil, and M. Stiborova Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450 Chem. Biol. Interact. 139 2002 1 21
77. W.F. Hodnick, D.L. Duval, and R.S. Pardini Inhibition of mitochondrial respiration and cyanide-stimulated generation of reactive oxygen species by selected flavonoids Biochem. Pharmacol. 47 1994 573 580
78. P.C. Hollman, and M.B. Katan Absorption, metabolism and health effects of dietary flavonoids in man Biomed. Pharmacother. 51 1997 305 310
79. N.A. Hosea, G.P. Miller, and F.P. Guengerich Elucidation of distinct ligand binding sites for cytochrome P450 3A4 Biochemistry 39 2000 5929 5939
80. S.K. Hukkinen, A. Varhe, K.T. Olkkola, and P.J. Neuvonen Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice Clin. Pharmacol. Ther. 58 1995 127 131
81. A.R. Ibrahim, and Y.J. Abul-Hajj Aromatase inhibition by flavonoids J. Steroid Biochem. Mol. Biol. 37 1990 257 260
82. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, and M. Yamamoto Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 13 1999 76 86
83. C.R. Jefcoate, J.G. Liehr, R.J. Santen, T.R. Sutter, J.D. Yager, W. Yue, S.J. Santner, R. Tekmal, L. Demers, R. Pauley, F. Naftolin, G. Mor, and L. Berstein Tissue-specific synthesis and oxidative metabolism of estrogens J. Natl. Cancer Inst. Monogr. 2000 95 112
84. J. Jeyapaul, and A.K. Jaiswal Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma- glutamylcysteine synthetase heavy subunit gene Biochem. Pharmacol. 59 2000 1433 1439
85. G. Jurgenliemk, and A. Nahrstedt Phenolic compounds from Hypericum perforatum Planta Med. 68 2002 88 91
86. K.W. Kang, E.Y. Park, and S.G. Kim Activation of CCAAT/enhancer-binding protein beta by 2′-amino-3′-methoxyflavone (PD98059) leads to the induction of glutathione S- transferase A2 Carcinogenesis. 24 2003 475 482
87. Z.C. Kang, S.J. Tsai, and H. Lee Quercetin inhibits benzo[a]pyrene- induced DNA adducts in human Hep G2 cells by altering cytochrome P-450 1A1 gene expression Nutr. Cancer 35 1999 175 179
88. T. Kantola, K.T. Kivisto, and P.J. Neuvonen Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid Clin. Pharmacol. Ther. 63 1998 397 402
89. Y.C. Kao, C. Zhou, M. Sherman, C.A. Laughton, and S. Chen Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study Environ. Health Perspect. 106 1998 85 92
90. R. Kato Molecular pharmacological and toxicological studies of drug-metabolizing enzymes Yakugaku Zasshi 115 1995 661 680
91. K. Kawabata, T. Tanaka, S. Honjo, M. Kakumoto, A. Hara, H. Makita, N. Tatematsu, J. Ushida, H. Tsuda, and H. Mori Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis Int. J. Cancer 83 1999 381 386
92. J.T. Kellis Jr., and L.E. Vickery Inhibition of human estrogen synthetase (aromatase) by flavones Science 225 1984 1032 1034
93. V.P. Kelly, E.M. Ellis, M.M. Manson, S.A. Chanas, G.J. Moffat, R. McLeod, D.J. Judah, G.E. Neal, and J.D. Hayes Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H: quinone oxidoreductase in rat liver Cancer Res. 60 2000 957 969
94. U.M. Kent, M. Aviram, M. Rosenblat, and P.F. Hollenberg The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9 Drug Metab. Dispos. 30 2002 709 715
95. D.H. Kim, Y.H. Jin, J.B. Park, and K. Kobashi Silymarin and its components are inhibitors of beta-glucuronidase Biol. Pharm. Bull. 17 1994 443 445
96. C. King, W. Tang, J. Ngui, T. Tephly, and M. Braun Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac Toxicol. Sci. 61 2001 49 53
97. T. Kishida, M. Nagamoto, Y. Ohtsu, M. Watakabe, D. Ohshima, K. Nashiki, T. Mizushige, T. Izumi, A. Obata, and K. Ebihara Lack of an inducible effect of dietary soy isoflavones on the mRNA abundance of hepatic cytochrome P-450 isozymes in rats Biosci. Biotechnol. Biochem. 68 2004 508 515
98. Y. Kobayashi, N. Ohshiro, M. Suzuki, T. Sasaki, S. Tokuyama, T. Yoshida, and T. Yamamoto Sex-related effect of hemin on cytochrome P450 and drug-metabolizing enzymes in rat liver J. Toxicol. Sci. 25 2000 213 222
99. M.C. Kohn, N.J. Walker, A.H. Kim, and C.J. Portier Physiological modeling of a proposed mechanism of enzyme induction by TCDD Toxicology 162 2001 193 208
100. H. Kohno, T. Tanaka, K. Kawabata, Y. Hirose, S. Sugie, H. Tsuda, and H. Mori Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats Int. J. Cancer 101 2002 461 468
101. A.P. Koley, R.C. Robinson, and F.K. Friedman Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics Biochimie 78 1996 706 713
102. S. Kronenberg, C. Esser, and C. Carlberg An aryl hydrocarbon receptor conformation acts as the functional core of nuclear dioxin signaling Nucleic Acids Res. 28 2000 2286 2291
103. J. Kuhnau The flavonoids. A class of semi-essential food components: their role in human nutrition World Rev. Nutr. Diet 24 1976 117 191
104. N. Kumar, K. Allen, D. Riccardi, A. Kazi, and J. Heine Isoflavones in breast cancer chemoprevention: where do we go from here? Front Biosci. 9 2004 2927 2934
105. H.H. Kupferschmidt, H.R. Ha, W.H. Ziegler, P.J. Meier, and S. Krahenbuhl Interaction between grapefruit juice and midazolam in humans Clin. Pharmacol. Ther. 58 1995 20 28
106. M.J. Laughton, P.J. Evans, M.A. Moroney, J.R. Hoult, and B. Halliwell Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability Biochem. Pharmacol. 42 1991 1673 1681
107. J.C. Le Bail, Y. Champavier, A.J. Chulia, and G. Habrioux Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells Life Sci. 66 2000 1281 1291
108. H.W. Leber, and S. Knauff Influence of silymarin on drug metabolizing enzymes in rat and man Arzneimittelforschung 26 1976 1603 1605
109. H. Lee, H.W. Wang, H.Y. Su, and N.J. Hao The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f] quinoline Mutagenesis 9 1994 101 106
110. S.K. Lee, L. Song, E. Mata-Greenwood, G.J. Kelloff, V.E. Steele, and J.M. Pezzuto Modulation of in vitro biomarkers of the carcinogenic process by chemopreventive agents Anticancer Res. 19 1999 35 44
111. A.J. Lewis, Y. Otake, U.K. Walle, and T. Walle Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase Xenobiotica 30 2000 253 261
112. J.J. Lilja, K.T. Kivisto, and P.J. Neuvonen Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors Clin. Pharmacol. Ther. 64 1998 477 483
113. C.N. Lin, T.H. Lee, M.F. Hsu, J.P. Wang, F.N. Ko, and C.M. Teng 2′,5′-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor J. Pharm. Pharmacol. 49 1997 530 536
114. J.H. Lin, and A.Y. Lu Inhibition and induction of cytochrome P450 and the clinical implications Clin. Pharmacokinet. 35 1998 361 390
115. K.O. Lindros, Y.A. Cai, and K.E. Penttila Role of ethanol-inducible cytochrome P-450 IIE1 in carbon tetrachloride-induced damage to centrilobular hepatocytes from ethanol-treated rats Hepatology 12 1990 1092 1097
116. T.T. Liu, N.S. Liang, Y. Li, F. Yang, Y. Lu, Z.Q. Meng, and L.S. Zhang Effects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats World J. Gastroenterol. 9 2003 2742 2744
117. C.J. MacDonald, H.P. Ciolino, and G.C. Yeh Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P50 1A1, 1A2, and 1B1 Cancer Res. 61 2001 3919 3924
118. M. Machala, R. Kubinova, P. Horavova, and V. Suchy Chemoprotective potentials of homoisoflavonoids and chalcones of Dracaena cinnabari: modulations of drug-metabolizing enzymes and antioxidant activity Phytother. Res. 15 2001 114 118
119. P.I. Mackenzie, I.S. Owens, B. Burchell, K.W. Bock, A. Bairoch, A. Belanger, S. Fournel-Gigleux, M. Green, D.W. Hum, T. Iyanagi, D. Lancet, P. Louisot, J. Magdalou, J.R. Chowdhury, J.K. Ritter, H. Schachter, T.R. Tephly, K.F. Tipton, and D.W. Nebert The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence Pharmacogenetics 7 1997 255 269
120. P.P. Maliakal, P.F. Coville, and S. Wanwimolruk Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats J. Pharm. Pharmacol. 53 2001 569 577
121. F. Marchetti, C. De Santi, M. Vietri, A. Pietrabissa, R. Spisni, F. Mosca, and G.M. Pacifici Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine Xenobiotica 31 2001 841 847
122. J.S. Markowitz, C.L. DeVane, D.W. Boulton, S.W. Carson, Z. Nahas, and S.C. Risch Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers Life Sci. 66 2000 PL133 PL139
123. J.S. Markowitz, J.L. Donovan, C.L. DeVane, R.M. Taylor, Y. Ruan, J.S. Wang, and K.D. Chavin Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme Jama 290 2003 1500 1504
124. T.L. McLemore, S. Adelberg, M.C. Liu, N.A. McMahon, S.J. Yu, W.C. Hubbard, M. Czerwinski, T.G. Wood, R. Storeng, and R.A. Lubet Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas J. Natl. Cancer Inst. 82 1990 1333 1339
125. M. McMahon, K. Itoh, M. Yamamoto, S.A. Chanas, C.J. Henderson, L.I. McLellan, C.R. Wolf, C. Cavin, and J.D. Hayes The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes Cancer Res. 61 2001 3299 3307
126. J.H. Meerman, D.P. Ringer, M.W. Coughtrie, K.J. Bamforth, and R.A. Gilissen Sulfation of carcinogenic aromatic hydroxylamines and hydroxamic acids by rat and human sulfotransferases: substrate specificity, developmental aspects and sex differences Chem. Biol. Interact. 92 1994 321 328
127. W.R. Miller, T.J. Anderson, and W.J. Jack Relationship between tumour aromatase activity, tumour characteristics and response to therapy J. Steroid Biochem. Mol. Biol. 37 1990 1055 1059
128. C.L. Miranda, G.L. Aponso, J.F. Stevens, M.L. Deinzer, and D.R. Buhler Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells Cancer Lett. 149 2000 21 29
129. B.T. Montgomery, C.Y. Young, D.L. Bilhartz, P.E. Andrews, J.L. Prescott, N.F. Thompson, and D.J. Tindall Hormonal regulation of prostate-specific antigen glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP Prostate 21 1992 63 73
130. L.B. Moore, B. Goodwin, S.A. Jones, G.B. Wisely, C.J. Serabjit-Singh, T.M. Willson, J.L. Collins, and S.A. Kliewer St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc. Natl. Acad. Sci. USA 97 2000 7500 7502
131. H. Mukhtar, Z.Y. Wang, S.K. Katiyar, and R. Agarwal Tea components: antimutagenic and anticarcinogenic effects Prev. Med. 21 1992 351 360
132. A. Nahrstedt, and V. Butterweck Biologically active and other chemical constituents of the herb of Hypericum perforatum L Pharmacopsychiatry 30 Suppl 2 1997 129 134
133. S.E. Nielsen, V. Breinholt, C. Cornett, and L.O. Dragsted Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavane nucleus Food Chem. Toxicol. 38 2000 739 746
134. W.A. Nijhoff, M.A. Bosboom, M.H. Smidt, and W.H. Peters Enhancement of rat hepatic and gastrointestinal glutathione and glutathione S-transferases by alpha-angelicalactone and flavone Carcinogenesis 16 1995 607 612
135. R.F. Novak, and K.J. Woodcroft The alcohol-inducible form of cytochrome P450 (CYP2E1): role in toxicology and regulation of expression Arch. Pharm. Res. 23 2000 267 282
136. R.S Obach Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression J. Pharmacol. Exp. Ther. 294 2000 88 95
137. M.T. Obermeier, R.E. White, and C.S. Yang Effects of bioflavonoids on hepatic P450 activities Xenobiotica 25 1995 575 584
138. K. Ohkimoto, M.Y. Liu, M. Suiko, Y. Sakakibara, and M.C. Liu Characterization of a zebrafish estrogen-sulfating cytosolic sulfotransferase: inhibitory effects and mechanism of action of phytoestrogens Chem. Biol. Interact. 147 2004 1 7
139. Y. Otake, A.L. Nolan, U.K. Walle, and T. Walle Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells J. Steroid Biochem. Mol. Biol. 73 2000 265 270
140. T.G. Pai, M. Suiko, Y. Sakakibara, and M.C. Liu Sulfation of flavonoids and other phenolic dietary compounds by the human cytosolic sulfotransferases Biochem. Biophys. Res. Commun. 285 2001 1175 1179
141. C. Pelissero, M.J. Lenczowski, D. Chinzi, B. Davail-Cuisset, J.P. Sumpter, and A. Fostier Effects of flavonoids on aromatase activity, an in vitro study J. Steroid Biochem. Mol. Biol. 57 1996 215 223
142. W.X. Peng, H.D. Li, and H.H. Zhou Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers Eur. J. Clin. Pharmacol. 59 2003 237 241
143. W.H. Peters, L. Kock, F.M. Nagengast, and P.G. Kremers Biotransformation enzymes in human intestine: critical low levels in the colon? Gut 32 1991 408 412
144. W.H. Peters, H.M. Roelofs, M.P. Hectors, F.M. Nagengast, and J.B. Jansen Glutathione and glutathione S-transferases in Barrett's epithelium Br. J. Cancer 67 1993 1413 1417
145. M. Picq, M. Dubois, A.F. Prigent, G. Nemoz, and H. Pacheco Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds Biochem. Int. 18 1989 47 57
146. S.C. Piscitelli, E. Formentini, A.H. Burstein, R. Alfaro, S. Jagannatha, and J. Falloon Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers Pharmacotherapy 22 2002 551 556
147. C. Pouget, C. Fagnere, J.P. Basly, A.E. Besson, Y. Champavier, G. Habrioux, and A.J. Chulia Synthesis and aromatase inhibitory activity of flavanones Pharm. Res. 19 2002 286 291
148. M. Ramos-Gomez, M.K. Kwak, P.M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T.W. Kensler Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in NRF2 transcription factor-deficient mice Proc. Natl. Acad. Sci. USA 98 2001 3410 3415
149. G.M. Raso, R. Meli, G. Di Carlo, M. Pacilio, and R. Di Carlo Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1 Life Sci. 68 2001 921 931
150. S. Rendic, and F.J. Di Carlo Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors Drug Metab. Rev. 29 1997 413 580
151. D.W. Roberts, D.R. Doerge, M.I. Churchwell, G. Gamboa da Costa, M.M. Marques, and W.H. Tolleson Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover) J. Agric. Food. Chem. 52 2004 6623 6632
152. N. Saarinen, S.C. Joshi, M. Ahotupa, X. Li, J. Ammala, S. Makela, and R. Santti No evidence for the in vivo activity of aromatase-inhibiting flavonoids J. Steroid Biochem. Mol. Biol. 78 2001 231 239
153. A. Scalbert, and G. Williamson Dietary intake and bioavailability of polyphenols J. Nutr. 130 2000 2073S 2085S
154. T. Schewe, H. Kuhn, and H. Sies Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase J. Nutr. 132 2002 1825 1829
155. K.D. Setchell, N.M. Brown, L. Zimmer-Nechemias, W.T. Brashear, B.E. Wolfe, A.S. Kirschner, and J.E. Heubi Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability Am. J. Clin. Nutr. 76 2002 447 453
156. S. Sharma, and S. Sultana Modulatory effect of soy isoflavones on biochemical alterations mediated by TPA in mouse skin model Food Chem. Toxicol. 42 2004 1669 1675
157. S.Y. Sheu, C.H. Lai, and H.C. Chiang Inhibition of xanthine oxidase by purpurogallin and silymarin group Anticancer Res. 18 1998 263 267
158. H. Shih, G.V. Pickwell, and L.C. Quattrochi Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer Arch. Biochem. Biophys. 373 2000 287 294
159. Y. Shukla, and P. Taneja Anticarcinogenic effect of black tea on pulmonary tumors in Swiss albino mice Cancer Lett. 176 2002 137 141
160. C.P. Siegers, L. Bartels, and D. Riemann Effects of fasting and glutathione depletors on the GSH-dependent enzyme system in the gastrointestinal mucosa of the rat Pharmacology. 38 1989 121 128
161. M.H. Siess, J. Leclerc, M.C. Canivenc-Lavier, P. Rat, and M. Suschetet Heterogenous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes Toxicol. Appl. Pharmacol. 130 1995 73 78
162. M.H. Siess, J.P. Mas, M.C. Canivenc-Lavier, and M. Suschetet Time course of induction of rat hepatic drug-metabolizing enzyme activities following dietary administration of flavonoids J. Toxicol. Environ. Health 49 1996 481 496
163. V. Simanek, D. Walterova, J. Vicar, J. Urbanikova, V. Kren, M. Modriansky, N. Skottova, and J. Ulrichova Silymarin-an extract from the milk thistle (Silybum marianum)-is it a drug or nutritional supplement? Ceska Slov. Farm. 50 2001 66 69
164. L. Sivaraman, M.P. Leatham, J. Yee, L.R. Wilkens, A.F. Lau, and L. Le Marchand CYP1A1 genetic polymorphisms and in situ colorectal cancer Cancer Res. 54 1994 3692 3695
165. T.J. Smith, Z. Guo, F.P. Guengerich, and C.S. Yang Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate Carcinogenesis 17 1996 809 813
166. O.S. Sohn, A. Surace, E.S. Fiala, J.P. Richie Jr., S. Colosimo, E. Zang, and J.H. Weisburger Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat Xenobiotica 24 1994 119 127
167. G.J. Soleas, E.P. Diamandis, and D.M. Goldberg Resveratrol: a molecule whose time has come? and gone? Clin. Biochem. 30 1997 91 113
168. X.Y. Sun, C.A. Plouzek, J.P. Henry, T.T. Wang, and J.M. Phang Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells Cancer Res. 58 1998 2379 2384
169. P. Talalay, M.J. De Long, and H.J. Prochaska Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis Proc. Natl. Acad. Sci. USA. 85 1988 8261 8265
170. H. Tamura, and M. Matsui Inhibitory effects of green tea and grape juice on the phenol sulfotransferase activity of mouse intestines and human colon carcinoma cell line, Caco-2 Biol. Pharm. Bull. 23 2000 695 699
171. T. Tanaka, K. Kawabata, M. Kakumoto, H. Makita, J. Ushida, S. Honjo, A. Hara, H. Tsuda, and H. Mori Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats Carcinogenesis 20 1999 1477 1484
172. I.B. Tsyrlov, V.M. Mikhailenko, and H.V. Gelboin Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids Biochim. Biophys. Acta 1205 1994 325 335
173. R.H. Tukey, and C.P. Strassburg Human UDP-glucuronosyltransferases: metabolism, expression, and disease Ann. Rev. Pharmacol. Toxicol. 40 2000 581 616
174. Y. Uda, K.R. Price, G. Williamson, and M.J. Rhodes Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids Cancer Lett. 120 1997 213 216
175. Y.F. Ueng, Y.L. Chang, Y. Oda, S.S. Park, J.F. Liao, M.F. Lin, and C.F. Chen In vitro and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liver Life Sci. 65 1999 2591 2602
176. Y.F. Ueng, T. Kuwabara, Y.J. Chun, and F.P. Guengerich Cooperativity in oxidations catalyzed by cytochrome P450 3A4 Biochemistry 36 1997 370 381
177. A. Umemoto, K. Komaki, Y. Monden, M. Suwa, Y. Kanno, M. Kitagawa, M. Suzuki, C.X. Lin, Y. Ueyama, M.A. Momen, A. Ravindernath, and S. Shibutani Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice Chem. Res. Toxicol. 14 2001 1006 1013
178. E.M. van der Logt, H.M. Roelofs, F.M. Nagengast, and W.H. Peters Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens Carcinogenesis 24 2003 1651 1656
179. J.J. van Zanden, O. Ben Hamman, M.L. van Iersel, S. Boeren, N.H. Cnubben, M. Lo Bello, J. Vervoort, P.J. van Bladeren, and I.M. Rietjens Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin Chem. Biol. Interact. 145 2003 139 148
180. R. Venkataramanan, V. Ramachandran, B.J. Komoroski, S. Zhang, P.L. Schiff, and S.C. Strom Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures Drug Metab. Dispos. 28 2000 1270 1273
181. M.L. Veronese, L.P. Gillen, J.P. Burke, E.P. Dorval, W.W. Hauck, E. Pequignot, S.A. Waldman, and H.E. Greenberg Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice J. Clin. Pharmacol. 43 2003 831 839
182. T. Walle, E.A. Eaton, and U.K. Walle Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase Biochem. Pharmacol. 50 1995 731 734
183. T. Walle, Y. Otake, A. Galijatovic, J.K. Ritter, and U.K. Walle Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2 Drug Metab. Dispos. 28 2000 1077 1082
184. U.K. Walle, and T. Walle Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements Drug Metab. Dispos. 30 2002 564 569
185. C. Wang, T. Makela, T. Hase, H. Adlercreutz, and M.S. Kurzer Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes J. Steroid Biochem. Mol. Biol. 50 1994 205 212
186. H. Wang, Y. Wang, Z.Y. Chen, F.L. Chan, and L.K. Leung Hydroxychalcones exhibit differential effects on XRE transactivation Toxicology 207 2005 303 313
187. W. Wang, L.Q. Liu, C.M. Higuchi, and H. Chen Induction of NADPH: quinone reductase by dietary phytoestrogens in colonic Colo205 cells Biochem. Pharmacol. 56 1998 189 195
188. Z. Wang, J.C. Gorski, M.A. Hamman, S.M. Huang, L.J. Lesko, and S.D. Hall The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity Clin. Pharmacol. Ther. 70 2001 317 326
189. Z.Y. Wang, M. Das, D.R. Bickers, and H. Mukhtar Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450 Drug Metab. Dispos. 16 1988 98 103
190. L.W. Wattenberg, M.A. Page, and J.L. Leong Induction of increased benzpyrene hydroxylase activity by flavones and related compounds Cancer Res. 28 1968 934 937
191. A. Weber, R. Jager, A. Borner, G. Klinger, R. Vollanth, K. Matthey, and A. Balogh Can grapefruit juice influence ethinylestradiol bioavailability? Contraception 53 1996 41 47
192. X. Wen, U.K. Walle, and T. Walle 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells Carcinogenesis 26 2005 803 809
193. J.M. Wentworth, M. Agostini, J. Love, J.W. Schwabe, and V.K. Chatterjee St John's wort, a herbal antidepressant, activates the steroid X receptor J. Endocrinol. 166 2000 R11 R16
194. J.A. Williams, B.J. Ring, V.E. Cantrell, K. Campanale, D.R. Jones, S.D. Hall, and S.A. Wrighton Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes Drug Metab. Dispos. 30 2002 1266 1273
195. C.K. Wong, and W.M. Keung Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2) Biochem. Biophys. Res. Commun. 233 1997 579 583
196. A.W. Wood, D.S. Smith, R.L. Chang, M.T. Huang, and A.H. Conney Effects of flavonoids on the metabolism of xenobiotics Prog. Clin. Biol. Res. 213 1986 195 210
197. Y. Yamazoe, K. Nagata, K. Yoshinari, K. Fujita, T. Shiraga, and K. Iwasaki Sulfotransferase catalyzing sulfation of heterocyclic amines Cancer Lett. 143 1999 103 107
198. G.Y. Yang, Z. Liu, D.N. Seril, J. Liao, W. Ding, S. Kim, F. Bondoc, and C.S. Yang Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice Carcinogenesis 18 1997 2361 2365
199. S. Yannai, A.J. Day, G. Williamson, and M.J. Rhodes Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines Food Chem. Toxicol. 36 1998 623 630
200. G.C. Yee, D.L. Stanley, L.J. Pessa, T. Dalla Costa, S.E. Beltz, J. Ruiz, and D.T. Lowenthal Effect of grapefruit juice on blood cyclosporin concentration Lancet 345 1995 955 956
201. S. Zhai, R. Dai, F.K. Friedman, and R.E. Vestal Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids Drug Metab. Dispos. 26 1998 989 992
202. Y. Zhang, and L.Z. Benet The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein Clin. Pharmacokinet. 40 2001 159 168
203. J. Zhao, and R. Agarwal Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention Carcinogenesis 20 1999 2101 2108
204. C. Zhou, D. Zhou, J. Esteban, J. Murai, P.K. Siiteri, S. Wilczynski, and S. Chen Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction J. Steroid Biochem. Mol. Biol. 59 1996 163 171
205. S. Zhou, Y. Gao, W. Jiang, M. Huang, A. Xu, and J.W. Paxton Interactions of herbs with cytochrome P450 Drug Metab. Rev. 35 2003 35 98
206. S. Zhou, H.L. Koh, Y. Gao, Z.Y. Gong, and E.J. Lee Herbal bioactivation: the good, the bad and the ugly Life Sci. 74 2004 935 968
207. B.T. Zhu, and A.H. Conney Functional role of estrogen metabolism in target cells: review and perspectives Carcinogenesis 19 1998 1 27
208. L. Zou, M.R. Harkey, and G.L. Henderson Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity Life Sci. 71 2002 1579 1589
209. R. Zuber, M. Modriansky, Z. Dvorak, P. Rohovsky, J. Ulrichova, V. Simanek, and P. Anzenbacher Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities Phytother. Res. 16 2002 632 638